Infliximab Exposure Associates With Radiologic Evidence of Healing in Patients With Crohn's Disease.
Fiche publication
Date publication
avril 2020
Journal
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Auteurs
Membres identifiés du Cancéropôle Est :
Pr PEYRIN-BIROULET Laurent
Tous les auteurs :
Bossuyt P, Dreesen E, Rimola J, Devuysere S, De Bruecker Y, Vanslembrouck R, Laurent V, Zappa M, Savoye-Collet C, Pariente B, Filippi J, Baert F, D'haens G, Laharie D, Peyrin-Biroulet L, Vermeire S,
Lien Pubmed
Résumé
Higher infliximab trough levels are associated with clinical and endoscopic remission in patients with Crohn's disease (CD). We investigated pharmacodynamic features of infliximab and radiological healing.
Mots clés
TAILORIX, anti-TNF agent, biomarker, prognostic factor, response to therapy
Référence
Clin. Gastroenterol. Hepatol.. 2020 Apr 28;: